These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10695727)

  • 1. Pathogenic autoantibodies to neuronal proteins in neurological disorders.
    Vincent A; Lily O; Palace J
    J Neuroimmunol; 1999 Dec; 100(1-2):169-80. PubMed ID: 10695727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunology of disorders of neuromuscular transmission.
    Vincent A
    Acta Neurol Scand Suppl; 2006; 183():1-7. PubMed ID: 16637918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to ion channels at the neuromuscular junction.
    Lang B; Vincent A
    Autoimmun Rev; 2003 Mar; 2(2):94-100. PubMed ID: 12848965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients.
    Newsom-Davis J; Leys K; Vincent A; Ferguson I; Modi G; Mills K
    J Neurol Neurosurg Psychiatry; 1991 May; 54(5):452-3. PubMed ID: 1650816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune myasthenia and Lambert-Eaton myasthenic syndrome. Physiopathologic concepts].
    Eymard B
    Ann Med Interne (Paris); 1989; 140(6):462-6. PubMed ID: 2696402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies, neurotoxins and the nervous system.
    Vincent A; Roberts M; Willison H; Lang B; Newsom-Davis J
    J Physiol Paris; 1995; 89(3):129-36. PubMed ID: 7581302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholine receptor antibodies in the Lambert-Eaton myasthenic syndrome.
    Katz JS; Wolfe GI; Bryan WW; Tintner R; Barohn RJ
    Neurology; 1998 Feb; 50(2):470-5. PubMed ID: 9484374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies to acetylcholine receptor in patients with different clinical forms of myasthenia and Lambert-Eaton myasthenic syndrome].
    Sidnev DV; Karganov MIu; Shcherbakova NI; Alchinova IB; Sanadze AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):53-5. PubMed ID: 16457135
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoadsorption in patients with autoimmune ion channel disorders of the peripheral nervous system.
    Antozzi C
    Atheroscler Suppl; 2013 Jan; 14(1):219-22. PubMed ID: 23357168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in different forms of myasthenia gravis and in the Lambert-Eaton syndrome.
    Vincent A
    Handb Clin Neurol; 2008; 91():213-27. PubMed ID: 18631844
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunopathogenesis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Lisý L
    Bratisl Lek Listy; 1997 Apr; 98(4):217-20. PubMed ID: 9264830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis and myasthenic syndromes.
    Oosterhuis HJ; Kuks JB
    Curr Opin Neurol Neurosurg; 1992 Oct; 5(5):638-44. PubMed ID: 1392138
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia gravis and myasthenic syndrome.
    Antozzi C
    Neurol Sci; 2003 Oct; 24 Suppl 4():S260-3. PubMed ID: 14598056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological features of neurological paraneoplastic syndromes.
    Lorusso L; Hart IK; Giometto B; Pezzani R; Broome JC; Gritti D; Gasparetto C; Ricevuti G
    Int J Immunopathol Pharmacol; 2004; 17(2):135-44. PubMed ID: 15171814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lambert-Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels.
    Hajela RK; Huntoon KM; Atchison WD
    Muscle Nerve; 2015 Feb; 51(2):176-84. PubMed ID: 24862203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis with a paraneoplastic marker.
    Leavitt JA
    J Neuroophthalmol; 2000 Jun; 20(2):102-5. PubMed ID: 10870923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A myasthenic syndrome associated with combined autoantibodies to postsynaptic acetylcholine receptors and presynaptic voltage-gated calcium channels.
    Moschner C; Moser A; Kömpf D
    Eur Neurol; 1998 Aug; 40(2):110-1. PubMed ID: 9776630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.